Macrogenics reported $147.81M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US USD 24.06B 4.74B
AstraZeneca AZN:LN USD 20.22B 693M
Biogen BIIB:US USD 9.77B 24.9M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Daiichi Sankyo 4568:JP JPY 1.46T 90.16B
Eli Lilly And LLY:US USD 17.64B 524.7M
Genmab GEN:DC DKK 28.74B 3.25B
Geron GERN:US USD 222.07M 5.3M
Gilead Sciences GILD:US USD 13.9B 723M
Immunogen IMGN:US USD 330.42M 63.51M
Karyopharm Therapeutics KPTI:US USD 222.68M 19.77M
Macrogenics MGNX:US USD 147.81M 19.82M
Mirati Therapeutics MRTX:US USD 1.23B 22.86M
Puma Biotechnology PBYI:US USD 122.35M 8.07M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Seattle Genetics SGEN:US USD 2.76B 19.04M
Xencor XNCR:US USD 668M 82.06M